05.10.2018
- US gene therapy group Sangamo Therapeutics has completed its purchase of French biotech TxCell, which will now operate as a subsidiary of Sangamo and remain in Valbonne. The...
16.05.2017
- Major US drugmaker Pfizer is collaborating with Sangamo Therapeutics to develop and commercialize gene therapy programs for the rare blood disorder hemophilia A. The agreement...
